Evaluation of Apricoxib (Selective Cyclooxygenase 2 Inhibition) in Modulating T Regulatory Cells of Patients With Early Stage Non-small Cell Lung Cancer
Clinical trial NCT01532362 · TERMINATED
Trial details
- NCT number
- NCT01532362
- Sponsor
- Jonsson Comprehensive Cancer Center
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2012-05-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.